|
GLUD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.95049581725493E-11 |
| Normal-vs-Stage2 |
1.16050002940682E-09 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.514600E-01 |
| Stage1-vs-Stage3 |
8.10290000000657E-05 |
| Stage1-vs-Stage4 |
3.88519999505732E-08 |
| Stage2-vs-Stage3 |
9.002000E-02 |
| Stage2-vs-Stage4 |
3.360000E-03 |
| Stage3-vs-Stage4 |
1.827620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
8.68782823459924E-12 |
| Normal-vs-Asian |
1.508360E-02 |
| Caucasian-vs-AfricanAmerican |
1.246210E-01 |
| Caucasian-vs-Asian |
4.819200E-01 |
| AfricanAmerican-vs-Asian |
2.515400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
7.63900054323585E-10 |
| Male-vs-Female |
4.23299999999793E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.241600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.69586567011493E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
8.0836000004858E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.758600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.635800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.983400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.057000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.514400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.718000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.640700E-03 |
| Normal-vs-Grade 2 |
1.99750216367534E-11 |
| Normal-vs-Grade 3 |
1.63913327355658E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.257800E-01 |
| Grade 1-vs-Grade 3 |
2.178200E-01 |
| Grade 1-vs-Grade 4 |
1.582280E-04 |
| Grade 2-vs-Grade 3 |
2.288000E-02 |
| Grade 2-vs-Grade 4 |
2.29369967463811E-10 |
| Grade 3-vs-Grade 4 |
2.42579999999437E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.14389999986642E-07 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.56610002743918E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79654077672831E-12 |
| Normal-vs-N1 |
2.3781000002554E-07 |
| N0-vs-N1 |
1.448570E-01 |
|
|
